NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
7.42
+0.29 (4.07%)
At close: Jun 6, 2025, 4:00 PM
7.29
-0.13 (-1.75%)
After-hours: Jun 6, 2025, 6:10 PM EDT

NeoGenomics Statistics

Total Valuation

NeoGenomics has a market cap or net worth of $954.91 million. The enterprise value is $1.20 billion.

Market Cap 954.91M
Enterprise Value 1.20B

Important Dates

The next estimated earnings date is Monday, July 28, 2025, after market close.

Earnings Date Jul 28, 2025
Ex-Dividend Date n/a

Share Statistics

NeoGenomics has 128.69 million shares outstanding. The number of shares has increased by 0.96% in one year.

Current Share Class 128.69M
Shares Outstanding 128.69M
Shares Change (YoY) +0.96%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) 1.23%
Owned by Institutions (%) 93.45%
Float 120.34M

Valuation Ratios

PE Ratio n/a
Forward PE 38.73
PS Ratio 1.35
Forward PS 1.25
PB Ratio 1.03
P/TBV Ratio 27.90
P/FCF Ratio n/a
P/OCF Ratio 125.30
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.79
EV / EBITDA 1,826.98
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.68.

Current Ratio 2.05
Quick Ratio 1.82
Debt / Equity 0.68
Debt / EBITDA 49.11
Debt / FCF n/a
Interest Coverage -10.89

Financial Efficiency

Return on equity (ROE) is -8.57% and return on invested capital (ROIC) is -2.95%.

Return on Equity (ROE) -8.57%
Return on Assets (ROA) -2.75%
Return on Invested Capital (ROIC) -2.95%
Return on Capital Employed (ROCE) -5.40%
Revenue Per Employee $305,619
Profits Per Employee -$35,267
Employee Count 2,200
Asset Turnover 0.41
Inventory Turnover 14.95

Taxes

Income Tax -1.06M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.83% in the last 52 weeks. The beta is 1.64, so NeoGenomics's price volatility has been higher than the market average.

Beta (5Y) 1.64
52-Week Price Change -44.83%
50-Day Moving Average 8.40
200-Day Moving Average 12.99
Relative Strength Index (RSI) 43.70
Average Volume (20 Days) 1,566,286

Short Selling Information

Short Interest 6.28M
Short Previous Month 4.75M
Short % of Shares Out 4.88%
Short % of Float 5.22%
Short Ratio (days to cover) 2.16

Income Statement

In the last 12 months, NeoGenomics had revenue of $672.36 million and -$77.59 million in losses. Loss per share was -$0.61.

Revenue 672.36M
Gross Profit 297.88M
Operating Income -71.35M
Pretax Income -83.44M
Net Income -77.59M
EBITDA 657,000
EBIT -71.35M
Loss Per Share -$0.61
Full Income Statement

Balance Sheet

The company has $358.08 million in cash and $604.78 million in debt, giving a net cash position of -$246.70 million or -$1.92 per share.

Cash & Cash Equivalents 358.08M
Total Debt 604.78M
Net Cash -246.70M
Net Cash Per Share -$1.92
Equity (Book Value) 888.27M
Book Value Per Share 6.92
Working Capital 294.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $7.61 million and capital expenditures -$39.98 million, giving a free cash flow of -$32.37 million.

Operating Cash Flow 7.61M
Capital Expenditures -39.98M
Free Cash Flow -32.37M
FCF Per Share -$0.25
Full Cash Flow Statement

Margins

Gross margin is 44.30%, with operating and profit margins of -10.61% and -11.54%.

Gross Margin 44.30%
Operating Margin -10.61%
Pretax Margin -11.70%
Profit Margin -11.54%
EBITDA Margin 0.10%
EBIT Margin -10.61%
FCF Margin n/a

Dividends & Yields

NeoGenomics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.96%
Shareholder Yield -0.96%
Earnings Yield -8.14%
FCF Yield -3.39%
Dividend Details

Analyst Forecast

The average price target for NeoGenomics is $13.31, which is 79.38% higher than the current price. The consensus rating is "Buy".

Price Target $13.31
Price Target Difference 79.38%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 16, 2003. It was a reverse split with a ratio of 0.01:1.

Last Split Date Apr 16, 2003
Split Type Reverse
Split Ratio 0.01:1

Scores

NeoGenomics has an Altman Z-Score of 1.75 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.75
Piotroski F-Score 5